Author:
Triby C.,Carrier P.,Peyrade F.,Mounier N.,Fontana X.,Chaborel J.-P.,Tessonnier L.,Benisvy D.,Razzouk M.,Bussière F.,Darcourt J.
Subject
Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology,Biophysics
Reference77 articles.
1. Kosary CL, Miller BA, Hankey BF, Harras A, Edwards BK. Seer cancer statistics review. 1995.
2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000; 36:69–86.
3. Histologic conversion in the non-Hodgkin's lymphomas;Acker;J Clin Oncol,1983
4. History of antibody therapy for non-Hodgkin's lymphoma;Forero;Semin Oncol,2003
5. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program;McLaughlin;J Clin Oncol,1998